GR851296B - - Google Patents

Info

Publication number
GR851296B
GR851296B GR851296A GR850101296A GR851296B GR 851296 B GR851296 B GR 851296B GR 851296 A GR851296 A GR 851296A GR 850101296 A GR850101296 A GR 850101296A GR 851296 B GR851296 B GR 851296B
Authority
GR
Greece
Application number
GR851296A
Other languages
Greek (el)
Inventor
D A Dr Roberts
S F Dr Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848413685A external-priority patent/GB8413685D0/en
Priority claimed from GB848427167A external-priority patent/GB8427167D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of GR851296B publication Critical patent/GR851296B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR851296A 1984-05-29 1985-05-27 GR851296B (US20100223739A1-20100909-C00005.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848413685A GB8413685D0 (en) 1984-05-29 1984-05-29 Quinolone inotropic agents
GB848427167A GB8427167D0 (en) 1984-10-26 1984-10-26 Quinoline inotropic agents

Publications (1)

Publication Number Publication Date
GR851296B true GR851296B (US20100223739A1-20100909-C00005.png) 1985-11-25

Family

ID=26287793

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851296A GR851296B (US20100223739A1-20100909-C00005.png) 1984-05-29 1985-05-27

Country Status (18)

Country Link
US (3) US4728653A (US20100223739A1-20100909-C00005.png)
EP (1) EP0166533B1 (US20100223739A1-20100909-C00005.png)
KR (1) KR870001167B1 (US20100223739A1-20100909-C00005.png)
AU (1) AU562081B2 (US20100223739A1-20100909-C00005.png)
CA (1) CA1292234C (US20100223739A1-20100909-C00005.png)
DE (1) DE3577091D1 (US20100223739A1-20100909-C00005.png)
DK (1) DK236085A (US20100223739A1-20100909-C00005.png)
EG (1) EG17344A (US20100223739A1-20100909-C00005.png)
ES (1) ES8608874A1 (US20100223739A1-20100909-C00005.png)
FI (1) FI852123L (US20100223739A1-20100909-C00005.png)
GR (1) GR851296B (US20100223739A1-20100909-C00005.png)
HU (1) HU195961B (US20100223739A1-20100909-C00005.png)
IL (1) IL75326A (US20100223739A1-20100909-C00005.png)
NO (1) NO163186B (US20100223739A1-20100909-C00005.png)
NZ (1) NZ212209A (US20100223739A1-20100909-C00005.png)
PL (1) PL145325B1 (US20100223739A1-20100909-C00005.png)
PT (1) PT80533B (US20100223739A1-20100909-C00005.png)
YU (1) YU44774B (US20100223739A1-20100909-C00005.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735948A (en) * 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
ZA859091B (en) * 1984-12-24 1987-07-29 Warner Lambert Co Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
GB8619902D0 (en) * 1986-08-15 1986-09-24 Pfizer Ltd Quinolone cardiac stimulants
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
DE3819565A1 (de) * 1988-06-09 1990-04-12 Hoechst Ag Verfahren zur herstellung von 4-nitro-3-trifluormethyl-anilin
SK207490A3 (en) * 1989-05-05 1998-08-05 Rhone Poulenc Agrochimie 1-arylimidazoles, method of preparation thereof, use and agent containing 1-arylimidazoles
US5223525A (en) * 1989-05-05 1993-06-29 Rhone-Poulenc Ag Company Pesticidal 1-arylimidazoles
KR0164842B1 (ko) * 1990-03-24 1999-01-15 손정삼 신규 벤즈옥사진, 벤조티아진 유도체 및 그 제조방법
US5200419A (en) * 1990-05-21 1993-04-06 Warner-Lambert Company Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
AU751139B2 (en) * 1997-10-13 2002-08-08 Astellas Pharma Inc. Amide derivative
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
PL353792A1 (en) 1999-08-27 2003-12-01 Ligand Pharmaceuticals Incorporatedligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6573382B2 (en) * 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
AU2002322456A1 (en) * 2001-06-29 2003-03-03 Aaipharma, Inc. Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone
WO2003002120A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6660864B2 (en) * 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) * 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002121A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6657061B2 (en) * 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
AU2004266160A1 (en) * 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
AU2013205820B2 (en) * 2005-06-09 2015-11-26 Novartis Ag Process for the synthesis of organic compounds
MY146795A (en) 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
KR20100058660A (ko) * 2007-10-23 2010-06-03 테바 파마슈티컬 인더스트리즈 리미티드 다사티닙 다형체 및 이의 제조 방법
EP3679028A1 (en) 2017-09-04 2020-07-15 C4 Therapeutics, Inc. Dihydroquinolinones

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
JPS5473783A (en) * 1977-11-15 1979-06-13 Otsuka Pharmaceut Co Ltd Pyridine derivative
DE2815956A1 (de) * 1978-04-13 1979-10-18 Bayer Ag Verfahren zur herstellung von in 2-stellung substituierten triazolen-1,2,3
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
JPS5576872A (en) * 1978-12-06 1980-06-10 Yoshitomi Pharmaceut Ind Ltd Imidazolidinone derivative
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
EP0102046A1 (en) * 1982-08-26 1984-03-07 Schering Corporation Tricyclic lactams, method for making them, pharmaceutical compositions containing them
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4591591A (en) * 1984-03-08 1986-05-27 Eli Lilly And Company Pyridazinone derivatives as inotropic agents

Also Published As

Publication number Publication date
PL145325B1 (en) 1988-09-30
NO163186B (no) 1990-01-08
EG17344A (en) 1991-08-30
DK236085D0 (da) 1985-05-28
US4837334A (en) 1989-06-06
HUT40642A (en) 1987-01-28
KR870001167B1 (ko) 1987-06-15
IL75326A (en) 1988-09-30
ES543514A0 (es) 1986-09-01
YU44774B (en) 1991-02-28
US4728653A (en) 1988-03-01
YU88985A (en) 1987-12-31
AU4303285A (en) 1985-12-05
ES8608874A1 (es) 1986-09-01
NO852124L (no) 1985-12-02
PT80533B (en) 1987-04-06
EP0166533A1 (en) 1986-01-02
DE3577091D1 (en) 1990-05-17
FI852123A0 (fi) 1985-05-28
US4900839A (en) 1990-02-13
NZ212209A (en) 1988-08-30
IL75326A0 (en) 1985-09-29
HU195961B (en) 1988-08-29
EP0166533B1 (en) 1990-04-11
CA1292234C (en) 1991-11-19
PT80533A (en) 1985-06-01
DK236085A (da) 1985-11-30
KR850008675A (ko) 1985-12-21
PL253689A1 (en) 1986-07-01
AU562081B2 (en) 1987-05-28
FI852123L (fi) 1985-11-30

Similar Documents

Publication Publication Date Title
GR851976B (US20100223739A1-20100909-C00005.png)
GR850520B (US20100223739A1-20100909-C00005.png)
GR851296B (US20100223739A1-20100909-C00005.png)
GR851468B (US20100223739A1-20100909-C00005.png)
GR851736B (US20100223739A1-20100909-C00005.png)
AT379850B (US20100223739A1-20100909-C00005.png)
FR2585053B1 (US20100223739A1-20100909-C00005.png)
GR851761B (US20100223739A1-20100909-C00005.png)
GR851472B (US20100223739A1-20100909-C00005.png)
AU2557584A (US20100223739A1-20100909-C00005.png)
GR79880B (US20100223739A1-20100909-C00005.png)
GR74229B (US20100223739A1-20100909-C00005.png)
GR74222B (US20100223739A1-20100909-C00005.png)
GR73465B (US20100223739A1-20100909-C00005.png)
GB2125438A (US20100223739A1-20100909-C00005.png)
GR851856B (US20100223739A1-20100909-C00005.png)
AU2219783A (US20100223739A1-20100909-C00005.png)
BG44806A1 (US20100223739A1-20100909-C00005.png)
BG44749A1 (US20100223739A1-20100909-C00005.png)
BG44935A1 (US20100223739A1-20100909-C00005.png)
BG45025A1 (US20100223739A1-20100909-C00005.png)
BG45060A1 (US20100223739A1-20100909-C00005.png)
BG45079A1 (US20100223739A1-20100909-C00005.png)
BG45080A1 (US20100223739A1-20100909-C00005.png)
BG45091A1 (US20100223739A1-20100909-C00005.png)